Ono: Corebeta for Inj. 12.5 mg for Improving Image Quality in Coronary CT Angiography

October 3, 2011
Ono Pharmaceutical has launched Corebeta for Injection 12.5 mg (landiolol), the world’s first drug for improving image quality in coronary computed tomographic (CT) angiography. Corebeta contains the same active pharmaceutical ingredient as the company’s short-acting β1 blocker Onoact 50 mg...read more